In this study, our results suggest that the HIF-1α/BMAL1/ALDOC pathway functions to enhance anaerobic glycolysis in tumor cells, thus reducing the sensitivity of CRC to L-OHP. This evidence concerns the gene HIF1A and neoplasm.